Updates are available Correction dated 2025-01-02
Click to view Correction: https://doi.org/10.1007/s00401-024-02838-3
-
Authors
Jotanovic, Jelena
Boldt, Henning Bünsow
Burton, Mark
Andersen, Marianne Skovsager
Bengtsson, Daniel
Bontell, Thomas Olsson
Ekman, Bertil
Engström, Britt Edén
Feldt-Rasmussen, Ulla
Heck, Ansgar
Jakovcevic, Antonia
Jørgensen, Jens Otto L.
Kraljevic, Ivana
Kunicki, Jacek
Lindsay, John R.
Losa, Marco
Loughrey, Paul Benjamin
Maiter, Dominique
Maksymowicz, Maria
Manojlovic-Gacic, Emilija
Pahnke, Jens
Petersenn, Stephan
Petersson, Maria
Popovic, Vera
Ragnarsson, Oskar
Rasmussen, Åse Krogh
Reisz, Zita
Saeger, Wolfgang
Schalin-Jäntti, Camilla
Scheie, David
Terreni, Maria Rosa
Tynninen, Olli
Whitelaw, Ben
Burman, Pia
Casar-Borota, Olivera https://orcid.org/0000-0001-7376-7331
-
Funding
Funding for this research was provided by:
Pfizer AB (GRG number 70598835)
Recordati AB
Svenska Läkaresällskapet (SLS-961569)
Lions Cancerforskningsfond
U-CAN
Region Uppsala - Gullstrandstjänst
Region Uppsala - ALF
Kirsten og Freddy Johansens Fond
Helsinki University Hospital Research Funds
Finska Läkaresällskapet
Uppsala University
- License Information
-
More Information
Article History
Received: 20 July 2024
Revised: 1 November 2024
Accepted: 17 November 2024
First Online: 23 November 2024
Change Date: 16 December 2024
Change Type: Update
Change Details: The original article has been corrected. Table 2 revied version is updated.
Change Date: 2 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00401-024-02838-3
